We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Home Bancorp
HBCP
$566M
| $459K | ﹤0.01% |
10,925
-158
| -1% | -$5.78K |
|
2627
Seneca Foods Class A
SENEA
$1.21B
| $458K | ﹤0.01% |
8,740
-134
| -2% | -$7.02K |
|
2628
First Business Financial Services
FBIZ
$595M
| $456K | ﹤0.01% |
11,377
-147
| -1% | -$4.95K |
|
|
ONTF
2629
DELISTED
ON24
ONTF
| $455K | ﹤0.01% |
57,756
-600
| -1% | -$4.16K |
|
2630
RBB Bancorp
RBB
$455M
| $455K | ﹤0.01% |
23,878
-44
| -0.2% | -$657 |
|
2631
NWPX Infrastructure Inc
NWPX
$1.15B
| $454K | ﹤0.01% |
15,014
-48
| -0.3% | -$1.35K |
|
|
TRUE
2632
DELISTED
TrueCar
TRUE
| $454K | ﹤0.01% |
131,273
+405
| +0.3% | +$1.03K |
|
2633
Waterstone Financial
WSBF
$375M
| $454K | ﹤0.01% |
31,966
-752
| -2% | -$8.89K |
|
2634
Nano X Imaging
NNOX
$73.8M
| $454K | ﹤0.01% |
71,234
-3,655
| -5% | -$22.8K |
|
|
DSKE
2635
DELISTED
Daseke, Inc. Common Stock
DSKE
| $453K | ﹤0.01% |
55,923
-4,047
| -7% | -$19.6K |
|
2636
iRadimed
IRMD
$1.18B
| $452K | ﹤0.01% |
9,518
-87
| -0.9% | -$3.66K |
|
2637
Prime Medicine
PRME
$559M
| $451K | ﹤0.01% |
50,858
-101
| -0.2% | -$778 |
|
2638
Children's Place
PLCE
$59.8M
| $450K | ﹤0.01% |
19,362
+18
| +0.1% | +$438 |
|
2639
First Bank
FRBA
$454M
| $449K | ﹤0.01% |
30,531
-590
| -2% | -$7.32K |
|
2640
Atea Pharmaceuticals
AVIR
$420M
| $449K | ﹤0.01% |
147,116
+12,808
| +10% | +$38.8K |
|
|
SFIX
2641
Stitch Fix
SFIX
$560M
| $445K | ﹤0.01% |
124,668
-360
| -0.3% | -$1.27K |
|
|
AGS
2642
DELISTED
PlayAGS
AGS
| $444K | ﹤0.01% |
52,729
+16,904
| +47% | +$125K |
|
|
ENFN
2643
DELISTED
Enfusion, Inc.
ENFN
| $444K | ﹤0.01% |
45,787
+3,033
| +7% | +$28.3K |
|
2644
1-800-Flowers.com
FLWS
$258M
| $443K | ﹤0.01% |
41,130
-568
| -1% | -$4.86K |
|
2645
Phathom Pharmaceuticals
PHAT
$692M
| $443K | ﹤0.01% |
48,502
-8,035
| -14% | -$69.2K |
|
2646
Limoneira
LMNR
$251M
| $442K | ﹤0.01% |
21,432
+381
| +2% | +$6.16K |
|
|
BAY
2647
DELISTED
BAYER AG SPONS ADR
BAY
| $441K | ﹤0.01% |
47,805
+1,048
| +2% | +$9.67K |
|
|
ITOS
2648
DELISTED
iTeos Therapeutics
ITOS
| $440K | ﹤0.01% |
40,194
-28,803
| -42% | -$286K |
|
2649
Organogenesis Holdings
ORGO
$239M
| $435K | ﹤0.01% |
106,425
-1,030
| -1% | -$2.88K |
|
|
TELN
2650
DELISTED
TELENOR ASA
TELN
| $435K | ﹤0.01% |
37,853
-655
| -2% | -$7.53K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.